KTTA – pasithea therapeutics corp. (US:NASDAQ)
Stock Stats
News
Pasithea Therapeutics Announces PAS-004 Abstract Accepted for Poster Presentation at 2024 ASCO Annual Meeting
Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1 Trial Evaluating PAS-004 in RAS, NF1 and RAF Mutated Cancers [Yahoo! Finance]
Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1 Trial Evaluating PAS-004 in RAS, NF1 and RAF Mutated Cancers
Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004 [Yahoo! Finance]
Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004
Form 4/A Pasithea Therapeutics For: Mar 01 Filed by: Marques Tiago
Form 4/A Pasithea Therapeutics For: Mar 01 Filed by: Novak Alfred J
Form 4/A Pasithea Therapeutics For: Mar 01 Filed by: STEINMAN LAWRENCE
Form 4/A Pasithea Therapeutics For: Mar 01 Filed by: Leahy Emer
Form 4/A Pasithea Therapeutics For: Mar 01 Filed by: Schneiderman Daniel H
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.